The American Cancer Society and Genentech, a member of the Roche Group, are partnering to execute a $4 million collaborative effort to provide equitable access to every cancer patient and their families.
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
